Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	9 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Operating activities:
Net earnings	$ 434	$ 488
Adjustments to reconcile net earnings to net cash provided by operations:
Depreciation and amortization	169	162
Stock-based compensation	49	64
Deferred income taxes	135	(16)
Venture Agreement termination payment	(476)	0
Loss on divestiture	0	112
Other	(18)	(9)
Changes in:
Receivables, net	158	71
Inventories, net	(64)	(54)
Prepaid expenses and other current assets	(14)	(28)
Accounts payable and accrued liabilities	(12)	(87)
Operating lease right-of-use assets and liabilities, net	(5)	1
Income taxes payable / prepaid	(74)	(17)
Net cash provided by operations	282	687
Investing activities:
Capital expenditures	(121)	(145)
Proceeds from divestiture, net of cash divested	0	128
Other	1	(1)
Net cash used for investing activities	(120)	(18)
Financing activities:
Notes and loans payable, net	1,581	50
Treasury stock purchased	(256)	(257)
Cash dividends paid to Clorox stockholders	(452)	(452)
Cash dividends paid to noncontrolling interests	0	(16)
Issuance of common stock for employee stock plans and other	(16)	30
Net cash provided by (used for) financing activities	857	(645)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(2)	(2)
Net increase (decrease) in cash, cash equivalents and restricted cash	1,017	22
Cash, cash equivalents and restricted cash:
Beginning of period	170	207
End of period	$ 1,187	$ 229